American Academy of Neurology, April 18-22

Follow Drugslib on

By Physician’s Briefing Staff HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 29, 2026.

via HealthDay

The annual meeting of the American Academy of Neurology was held this year from April 18 to 22 in Chicago. Participants included clinicians, academicians, allied health professionals, and others interested in neurology. The conference highlighted recent advances in neurological disorders, with presentations focusing on the diagnosis, management, and treatment of disorders impacting the brain and nervous system.

"This year has been another great meeting," Paul George, M.D., Ph.D., from Stanford University in Palo Alto, California, and chair of the AAN Science Committee, told HealthDay. "All of the courses and science platform sessions and plenaries had a lot of good buzz and a lot of full rooms. Neurology is just advancing so quickly that there's always a lot of great, new items at the conference on topics ranging from headache to Alzheimer disease to movement disorders to stroke."

AAN: Multimodal Lifestyle Intervention Consistently Improves Cognition in Early Dementia

WEDNESDAY, April 22, 2026 -- For patients with early Alzheimer disease and mild cognitive impairment, cognition is consistently improved with multimodal lifestyle interventions, while monoclonal antibodies clear amyloid plaques but only modestly preserve cognition, according to research presented at the annual meeting of the American Academy of Neurology, held from April 18 to 22 in Chicago.

Read Full Text

AAN: Football Is Number One Source for Pediatric Traumatic Brain Injuries

THURSDAY, March 5, 2026 -- Football is the single leading source of pediatric sports-related traumatic brain injury, according to a study scheduled for presentation at the annual meeting of the American Academy of Neurology, to be held from April 18 to 22 in Chicago.

Read Full Text

AAN: More Parents Refusing Vitamin K for Newborns

MONDAY, March 2, 2026 -- Parental vitamin K refusal is uncommon but rising in the United States and internationally and poses a substantial neurological risk to newborns, according to research scheduled for presentation at the annual meeting of the American Academy of Neurology, to be held from April 18 to 22 in Chicago.

Read Full Text

AAN: GLP-1 Receptor Agonist Initiation for Chronic Migraine Tied to Improved Outcomes

MONDAY, March 2, 2026 -- For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists is associated with fewer emergency department visits and hospitalizations overall and less need for medications used to stop and prevent migraine attacks, according to a study scheduled for presentation at the annual meeting of the American Academy of Neurology, to be held from April 18 to 22 in Chicago.

Read Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-30 02:19

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords